Fosun International Holds 2025 Annual Results Presentation: Fosun has the Ability to Navigate Through Cycles

Rhea-AI Summary

Fosun International (OTC:FOSUF) reported 2025 revenue of RMB173.43 billion and adjusted industrial operation profit of RMB4 billion. Adjusted NAV was RMB133.5 billion (NAV per share HKD18.1). The Group booked a RMB23.4 billion non-cash impairment, largely real estate-related.

Core units generated RMB128.2 billion (74% of revenue); Fosun Pharma net profit rose 21.69% to RMB3.371 billion. Management announced a share buyback, asset disposals, a USD205 million bond tender, and targets to exceed RMB10 billion net profit and cut interest-bearing debt below RMB60 billion.

Positive

• Total revenue of RMB173.43 billion
• Fosun Pharma net profit up 21.69% to RMB3.371 billion
• Adjusted NAV RMB133.5 billion; NAV per share HKD18.1
• Core subsidiaries generated RMB128.2 billion (74% of Group revenue)
• Completed USD205 million tender offer for May 2026 bonds

Negative

• Non-cash book loss of RMB23.4 billion in 2025
• Real estate impairments accounted for ~55% of the RMB23.4 billion loss
• Non-core asset impairments accounted for ~45% of the RMB23.4 billion loss

Market Context

This announcement outlines Fosun’s 2025 performance, highlighting RMB173.43 billion in revenue and a...

Analysis

This announcement outlines Fosun’s 2025 performance, highlighting RMB173.43 billion in revenue and a sizable non-cash impairment-driven loss of RMB23.4 billion. Management stresses core segment strength, deleveraging via bond tenders, and a medium-term net profit goal above RMB10 billion. Historically, ESG-focused news often showed price divergence, so investors may watch execution on asset sales, debt reduction toward below RMB60 billion, and delivery on buyback and governance commitments.

Key Figures

Total revenue: RMB173.43 billion Industrial operation profit: RMB4 billion Adjusted NAV: RMB133.5 billion +5 more

8 metrics

Total revenue RMB173.43 billion Group revenue during 2025 Reporting Period

Industrial operation profit RMB4 billion Adjusted industrial operation profit in 2025

Adjusted NAV RMB133.5 billion Fosun International adjusted net asset value

NAV per share HKD18.1 Adjusted NAV per share

Core subsidiaries revenue RMB128.2 billion Revenue from four core subsidiaries, 74% of total

Fosun Pharma net profit RMB3.371 billion Net profit, up 21.69% year-on-year

Book loss 2025 RMB23.4 billion Non-cash impairments and revaluations in 2025

Bond repurchase USD205 million US dollar bonds maturing May 2026, full tender offer at par

Historical Context

5 past events · Latest: Feb 26 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 26	ESG reporting award	Positive	+2.0%	Recognition for ESG reporting and sustainability strategy, supported by large sustainability-linked loan.
Jan 21	ESG score improvement	Positive	-17.2%	Improved FTSE Russell ESG score and repeat FTSE4Good inclusion with strong governance metrics.
Dec 21	Multiple ESG awards	Positive	-11.5%	TVB Outstanding ESG Award plus recognitions for ESG practices and reporting across businesses.
Nov 20	ESG leadership award	Positive	-12.5%	Named ESG Leading Enterprise with high ESG ratings and highlighted climate and social initiatives.
Nov 6	Sustainability accolades	Positive	-1.1%	Gold Award and Best Sustainability Team recognizing ESG ratings and global healthcare reach.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent ESG- and recognition-focused news has often seen negative next-day moves despite positive headlines, indicating frequent divergence between news tone and price reaction.

Recent Company History

Over the past several months, Fosun’s news flow has centered on ESG recognition and sustainability leadership. Awards and index inclusions on Nov 6, Nov 20, Dec 21 2025, and Jan 21 2026 all highlighted strong governance and environmental credentials, yet often coincided with negative price reactions. The latest article shifts focus to 2025 financial results, large non-cash impairments, and balance sheet optimization, marking a move from ESG accolades toward operational and capital-structure themes.

Key Terms

net asset value, impairment, goodwill, intangible assets, +4 more

8 terms

net asset value financial

"Fosun International's adjusted net asset value (NAV) was RMB133.5 billion"

Net asset value is the total value of an investment fund's assets minus any liabilities, divided by the number of shares or units outstanding. It represents the per-share worth of the fund, similar to how the value of a house is determined by its total worth after debts are subtracted. Investors use it to gauge the true value of their holdings and to compare different investment options.

View in glossary

impairment financial

"made non-cash impairment provisions and value revaluations on certain real estate projects"

Impairment occurs when the value of an asset, such as property, equipment, or investments, drops below its recorded worth on the books. This situation signals that the asset may be less valuable than originally thought, similar to discovering that an item you own is worth less than what you paid for it. For investors, recognizing impairment is important because it can affect the overall financial health and future prospects of a business.

goodwill financial

"as well as goodwill and intangible assets of certain non-core business segments"

Goodwill is the extra value a buyer pays for a company above the measurable worth of its buildings, inventory and other tangible items, reflecting things like brand reputation, customer loyalty and expected future profits. Think of paying more for a café because of its famous name and regulars rather than its furniture alone. It matters to investors because changes in goodwill — for example a write-down if expected benefits don’t materialize — can reduce reported earnings and signal that past acquisitions aren’t delivering as hoped.

View in glossary

intangible assets financial

"goodwill and intangible assets of certain non-core business segments"

Non-physical resources a company owns that help it earn money, such as brand names, patents, customer lists, proprietary software, or trade secrets — think of them as a company’s reputation, recipes, or secret formulas that aren’t bricks and mortar. Investors care because these assets can create long-term income, protect market share, and boost the value of a business even if they don’t appear as cash; strong intangible assets can mean higher future profits and lower risk of competitors copying a company’s advantages.

View in glossary

full tender offer financial

"announcement earlier today of a full tender offer to repurchase its remaining US dollar bonds"

A full tender offer is a public proposal by a buyer to purchase all outstanding shares of a company at a specified price, often with the goal of taking control or taking the company private. For investors this matters because it usually offers a cash exit at a premium to the market price, can trigger swift ownership and strategy changes, and may remove the stock from public markets—so shareholders must weigh immediate payment against potential future value.

par value financial

"totaling approximately USD205 million, at 100% of par value"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

interest‑bearing debt financial

"reducing the Group's interest‑bearing debt to below RMB60 billion"

Interest-bearing debt is money a company has borrowed that requires regular interest payments, such as bank loans, bonds, or credit lines. It matters to investors because these payments reduce cash available for growth or dividends and increase financial risk—similar to how a household mortgage limits what you can spend each month; high levels can squeeze profits and make a company more vulnerable in downturns.

share buyback program financial

"The Company's Board of Directors has announced a share buyback program"

A share buyback program is when a company uses its cash to repurchase its own outstanding shares from the market, reducing the number of shares available to investors. That matters because it can raise the value of remaining shares and signal management's confidence in the business—similar to a bakery buying back unsold loafs to make each remaining loaf represent a larger share of its oven’s output—though buybacks can also affect cash available for other uses.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HONG KONG, April 1, 2026 /PRNewswire/ -- On 31 March, Fosun International held its 2025 annual results presentation in Shanghai. Guo Guangchang, Chairman of Fosun International; Wang Qunbin, Co-Chairman of Fosun International; Chen Qiyu, Co-CEO of Fosun International; Xu Xiaoliang, Co-CEO of Fosun International; Gong Ping, CFO of Fosun International, as well as a number of institutional investors and analysts attended the event.

On the evening of 30 March, Fosun International announced its 2025 annual results. During the Reporting Period, the Group's total revenue reached RMB173.43 billion, and adjusted industrial operation profit was RMB4 billion. Fosun International's adjusted net asset value (NAV) was RMB133.5 billion, with a NAV per share reaching HKD18.1. Its four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group's total revenue. Among them, Fosun Pharma achieved a net profit attributable to shareholders of the parent of RMB3.371 billion, representing a year-on-year increase of 21.69%. Fosun Insurance Portugal achieved a net profit attributable to owners of the parent of EUR201 million, up 15.8% year-on-year.

Compared to prior years, Fosun's results have largely remained stable. However, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators, as well as goodwill and intangible assets of certain non-core business segments. This resulted in a book loss of RMB23.4 billion in 2025, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%. These provisions do not affect the Company's overall operations and cash flow.

"Repairing the roof on a sunny day"

Guo Guangchang, Chairman of  Fosun International, emphasized that this impairment is akin to "repairing the roof on a sunny day", and from a long-term perspective, this impairment marks Fosun's entry into a new stage of development. "We will divest assets with low profitability and value below target, and focus our resources on core, high‑growth areas, steering the Company toward a leaner, healthier, and more sustainable future."

He explained that the operating results of Fosun's various business segments indicate that Fosun's core businesses remain solid. The pharmaceutical business has continued to make breakthroughs in its global expansion, with multiple products launched overseas and several promising pipeline products. The insurance business recorded growth both domestically and internationally, with Fosun Insurance Portugal expanding its business into regions such as Latin America and Africa. Meanwhile, domestic insurance companies, Fosun United Health Insurance and Pramerica Fosun Life Insurance, recorded significant profit increases. In the culture and tourism business, Club Med achieved record-high results.

"These businesses are capable of generating sustainable profit and cash flow, laying the foundation for Fosun's continued growth. Following this significant impairment, Fosun's future operating results will more accurately reflect the underlying quality of our core businesses," said Guo Guangchang.

No further impairment pressure is expected going forward

Following Fosun's results announcement, one of the market's key concern is the Company's future impairment pressure. At the results presentation, Wang Qunbin, Co-Chairman of Fosun International, stated that from the Group's perspective, prudent and adequate provisions were made, taking into account the actual operating environment of each impaired asset, the valuation cycle of the industry in which the asset operates, the projected growth and development of these assets and industries, and in accordance with the principle of prudence and the requirements of Hong Kong accounting standards. At present, Fosun is not expected to face further impairment pressure going forward. Since the Group announced its asset impairment, Fosun's management has proactively and promptly engaged with rating agencies, major partner banks and public bond investors, and has gained recognition from partners.

Wang Qunbin stated that while Fosun is confident in its financing capabilities in the future, and the domestic and international financing landscape and costs have improved significantly, Fosun remains committed to "streamlining operations and strengthening the business", focusing on development, and continuously improving its ratings.

High-quality breakthroughs in multiple core business areas

Regarding Fosun's key business directions, Chen Qiyu, Co-CEO of Fosun International, stated that Fosun will continue to focus on its core businesses to drive medium-to long-term value growth.

First, it will focus on its innovation and globalization strategies to pursue better and more sustainable value. Second, Fosun's robust global insurance business will drive healthy profit and cash flow growth, serving an important cornerstone for Fosun's future profit growth. Third, it will continue to advance the asset-light and global operations of its culture and tourism business to better leverage resources and drive efficient growth. In addition, it will strive to upgrade and achieve breakthroughs in high-quality assets and businesses such as Yuyuan's gold and jewelry business, Shede Spirits, and Hainan Mining.

Xu Xiaoliang, Co-CEO of Fosun International, stated that despite the high degree of uncertainty in the global macroeconomic environment last year, Fosun continued to optimize its financial structure and steadily enhanced business operations by focusing on its core businesses. It also achieved high-quality breakthroughs in multiple core business areas.

Revenue from its four major business segments—Health, Happiness, Wealth, and Intelligent Manufacturing—saw steady growth, overseas revenue continued to increase, innovation became a core competitive advantage, globalization accelerated further, and global operational capabilities continued to strengthen. Going forward, Fosun will continue to deepen its strategic focus, strengthen its global operational capabilities, intensify innovation efforts, and invest in the future with greater composure and determination to achieve long-term, sustainable value growth.

Fully confident in the Company's future development

Regarding external concerns about Fosun's financing channels and debt, Gong Ping, CFO of Fosun International, stated that the Group's diversified financing channels remain open and its cost of debt is steadily declining. Since 2025, Fosun International has completed four long-term bond issuances overseas and successfully issued multiple 2-year credit bonds domestically, effectively extending debt maturity and optimizing debt structure. The proportion of medium- and long-term debt has increased from 48.7% in 2024 to 53.5%. This includes Fosun's announcement earlier today of a full tender offer to repurchase its remaining US dollar bonds maturing in May 2026, totaling approximately USD205 million, at 100% of par value, with the repurchase funded by the Group's own funds.

Gong Ping added that Fosun will take a multi-pronged approach to streamline the Group's asset portfolio and enhance transparency, thereby accelerating valuation recovery. Management has set a clear  medium-term target of achieving a net profit attributable to shareholders of the parent of more than RMB10 billion, mainly by accelerating the sale of asset-heavy projects and non-core subsidiaries, optimizing the asset portfolio, reducing the Group's interest‑bearing debt to below RMB60 billion, and lowering financial expenses. At the same time, Fosun will actively explore ways to bring non-listed assets to the capital market.

Fosun's management expressed full confidence in the Company's future development at the results presentation. The Company's Board of Directors has announced a share buyback program. Fosun's major shareholder and management team will also increase their holdings in the shares of the Company. In the future, Fosun will actively explore and gradually introduce further measures to enhance shareholder returns, including optimizing the dividend mechanism, in line with operational improvements and cash flow conditions.

"I believe Fosun has the ability to navigate through cycles. While we may face some short-term challenges, these efforts will position Fosun for steadier, longer-term growth," said Guo Guangchang.

View original content:https://www.prnewswire.com/news-releases/fosun-international-holds-2025-annual-results-presentation-fosun-has-the-ability-to-navigate-through-cycles-302731273.html

SOURCE Fosun

FAQ

What were Fosun International's reported 2025 revenues and adjusted NAV (FOSUF)?

Fosun reported RMB173.43 billion in 2025 revenue and an adjusted NAV of RMB133.5 billion. According to the company, NAV per share reached HKD18.1, reflecting post-impairment asset valuations.

How large was Fosun's 2025 impairment and what drove the loss (FOSUF)?

Fosun recorded a RMB23.4 billion non-cash book loss in 2025, mainly impairment-driven. According to the company, about 55% related to real estate and 45% to non-core business assets.

What were key profit contributors for Fosun in 2025, including Fosun Pharma (FOSUF)?

Core businesses produced strong results; Fosun Pharma posted net profit of RMB3.371 billion, up 21.69%. According to the company, four core subsidiaries made up 74% of Group revenue.

What debt and capital actions did Fosun announce at the April 1, 2026 presentation (FOSUF)?

Fosun initiated a share buyback and completed a USD205 million tender offer for May 2026 bonds. According to the company, it aims to reduce interest-bearing debt below RMB60 billion.

Does Fosun expect further impairment pressure after the 2025 adjustments (FOSUF)?

Management said no further impairment pressure is expected and provisions were prudently made. According to the company, rating agencies and lenders have been engaged and financing access remains open.

What medium-term financial targets did Fosun set after the 2025 results (FOSUF)?

Fosun set a medium-term target of > RMB10 billion net profit attributable to shareholders and lowering interest-bearing debt below RMB60 billion. According to the company, asset sales and portfolio optimization will support these goals.